<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04247334</url>
  </required_header>
  <id_info>
    <org_study_id>1352651-9</org_study_id>
    <nct_id>NCT04247334</nct_id>
  </id_info>
  <brief_title>Inhibitory Control: Effects of Modulation</brief_title>
  <official_title>Brain Circuitry of Inhibitory Control: Effects of Modulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Butler Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Butler Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inhibitory control is relevant to many clinical disorders, including substance&#xD;
      abuse/dependence, obsessive-compulsive disorder, and attention-deficit hyperactivity&#xD;
      disorder. This proposal is designed to assess brain networks related to response inhibition&#xD;
      in healthy young adults, and use neuromodulation to change these networks and behavioral&#xD;
      performance on a response inhibition task. Having an understanding of the brain mechanisms&#xD;
      involved in response inhibition may enable us to improve pre-existing treatments for&#xD;
      disorders with inhibitory control difficulties.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 14, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>fMRI connectivity at rest</measure>
    <time_frame>2 weeks</time_frame>
    <description>Changes in resting state connectivity of the inhibitory control information</description>
  </primary_outcome>
  <primary_outcome>
    <measure>fMRI connectivity during a stop signal task</measure>
    <time_frame>2 weeks</time_frame>
    <description>Changes in task-based connectivity on the stop signal task</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">108</enrollment>
  <condition>Young Adults</condition>
  <arm_group>
    <arm_group_label>Cautious Participants</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants who have low scores on a self-report of inhibitory control abilities (BRIEF-Inhibit).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Impulsive Participants- Active Stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to active stimulation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Impulsive Participants- Sham Stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to sham stimulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct current stimulation</intervention_name>
    <description>20 minutes of 2 milliamp transcranial direct current stimulation</description>
    <arm_group_label>Impulsive Participants- Active Stimulation</arm_group_label>
    <arm_group_label>Impulsive Participants- Sham Stimulation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Low (&lt;1sd below the mean on the BRIEF-Inhibit) or high (&gt;1sd above the mean on&#xD;
             BRIEF-Inhibit scale)&#xD;
&#xD;
          2. English fluency to ensure comprehension of study measures and instructions.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Presence of medical conditions contraindicated for tDCS, including history of any&#xD;
             known intracranial pathology, epilepsy or seizures, traumatic brain injury, brain&#xD;
             tumor, stroke, implanted medical devices, current pregnancy or women of childbearing&#xD;
             age not using effective contraception, or any other serious medical conditions or&#xD;
             health problems that would interfere with participation (e.g., skin condition)&#xD;
&#xD;
          2. Inability to undergo MRI&#xD;
&#xD;
          3. Current substance abuse disorder&#xD;
&#xD;
          4. Currently prescribed psychiatric medications.&#xD;
&#xD;
          5. Active mania or psychosis&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>24 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicole McLaughlin, PhD</last_name>
    <phone>4014556608</phone>
    <email>nmclaughlin@butler.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Butler Hospital</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02906</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 24, 2020</study_first_submitted>
  <study_first_submitted_qc>January 28, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 30, 2020</study_first_posted>
  <last_update_submitted>September 8, 2021</last_update_submitted>
  <last_update_submitted_qc>September 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

